Data Sheet 1_Characteristics and outcomes of patients with LAM receiving sirolimus in France based on real-life data.pdf

<p>LAM is a rare multi-cystic lung disease for which treatment with sirolimus is indicated in cases of moderate or severe lung disease or declining lung function. The aim of this study was to describe patients treated with sirolimus for LAM and their outcomes. This retrospective observational...

Full description

Saved in:

Bibliographic Details
Main Author:	Vincent Cottin (321742) (author)
Other Authors:	Antoine Cases (20528729) (author), Virginie Bourdin (20528732) (author), Martine Reynaud-Gaubert (94691) (author), Sandrine Hirschi (18342283) (author), Mallorie Kerjouan (506025) (author), Rémi Diesler (20144646) (author), Brieux Chardès (20528735) (author), Stéphane Fiévez (20528738) (author), Nada Assi (3088770) (author), Aurélie Schmidt (3666916) (author), Hélène Denis (272333) (author), Lidwine Wémeau-Stervinou (473920) (author), Yurdagul Uzunhan (15448716) (author)
Published:	2025
Subjects:	Foetal Development and Medicine lymphangioleiomyomatosis lung-disease sirolimus rapamycin real-life data survival tuberous sclerosis complex
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Data Sheet 1_Characteristics and outcomes of patients with LAM receiving sirolimus in France based on real-life data.pdf

Similar Items